title: Respiratory tract immunization of non-human primates with a Newcastle disease virus-vectored vaccine candidate against Ebola virus elicits a neutralizing antibody response.
authors.affiliation: Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892-MSC, USA.
authors.forename: Joshua M
authors.initials: JM
authors.lastname: DiNapoli
authors.forename: Lijuan
authors.initials: L
authors.lastname: Yang
authors.forename: Siba K
authors.initials: SK
authors.lastname: Samal
authors.forename: Brian R
authors.initials: BR
authors.lastname: Murphy
authors.forename: Peter L
authors.initials: PL
authors.lastname: Collins
authors.forename: Alexander
authors.initials: A
authors.lastname: Bukreyev
mesh_terms: D000281:Administration, Intranasal; D000818:Animals; D057134:Antibodies, Neutralizing / Q000032:analysis*; D000914:Antibodies, Viral / Q000032:analysis*; D001769:Blood / Q000276:immunology; D012634:Bodily Secretions / Q000276:immunology; D046129:Ebola Vaccines / Q000008:administration & dosage / Q000276:immunology*; D029043:Ebolavirus / Q000235:genetics / Q000276:immunology*; D004797:Enzyme-Linked Immunosorbent Assay; D005822:Genetic Vectors; D019142:Hemorrhagic Fever, Ebola / Q000276:immunology / Q000517:prevention & control; D007070:Immunoglobulin A / Q000032:analysis; D007074:Immunoglobulin G / Q000032:analysis; D008253:Macaca mulatta; D009500:Neutralization Tests; D009522:Newcastle disease virus / Q000235:genetics*; D012137:Respiratory System / Q000276:immunology*; D014611:Vaccination / Q000379:methods*
chemical_list: D057134:Antibodies, Neutralizing; D000914:Antibodies, Viral; D046129:Ebola Vaccines; D007070:Immunoglobulin A; D007074:Immunoglobulin G